BL
Bleichroeder LP disclosed a 8.8% stake in CUE
Bleichroeder LP reported owning 8.8% of Cue Biopharma, Inc. (CUE) (663,009 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Bleichroeder LP reported owning 8.8% of Cue Biopharma, Inc. (CUE) (663,009 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.